Insmed, Inc. (INSM)
129.41
+2.13
(+1.67%)
USD |
NASDAQ |
Sep 11, 16:00
129.43
+0.02
(+0.02%)
After-Hours: 20:00
Insmed Max Drawdown (5Y) : 63.30% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 63.30% |
| July 31, 2026 | 63.30% |
| June 30, 2026 | 63.30% |
| May 31, 2026 | 63.30% |
| April 30, 2026 | 63.30% |
| March 31, 2026 | 63.30% |
| February 28, 2026 | 63.30% |
| January 31, 2026 | 63.30% |
| December 31, 2025 | 63.30% |
| November 30, 2025 | 63.30% |
| October 31, 2025 | 63.30% |
| September 30, 2025 | 63.30% |
| August 31, 2025 | 63.30% |
| July 31, 2025 | 63.30% |
| June 30, 2025 | 63.30% |
| May 31, 2025 | 63.30% |
| April 30, 2025 | 63.30% |
| March 31, 2025 | 63.30% |
| February 28, 2025 | 63.30% |
| January 31, 2025 | 63.30% |
| December 31, 2024 | 63.30% |
| November 30, 2024 | 63.30% |
| October 31, 2024 | 63.30% |
| September 30, 2024 | 63.30% |
| August 31, 2024 | 63.30% |
| Date | Value |
|---|---|
| July 31, 2024 | 63.30% |
| June 30, 2024 | 63.30% |
| May 31, 2024 | 63.30% |
| April 30, 2024 | 63.30% |
| March 31, 2024 | 63.30% |
| February 29, 2024 | 63.30% |
| January 31, 2024 | 63.30% |
| December 31, 2023 | 63.30% |
| November 30, 2023 | 64.84% |
| October 31, 2023 | 64.84% |
| September 30, 2023 | 64.84% |
| August 31, 2023 | 64.84% |
| July 31, 2023 | 64.84% |
| June 30, 2023 | 64.84% |
| May 31, 2023 | 64.84% |
| April 30, 2023 | 64.84% |
| March 31, 2023 | 64.84% |
| February 28, 2023 | 64.84% |
| January 31, 2023 | 64.84% |
| December 31, 2022 | 64.84% |
| November 30, 2022 | 64.84% |
| October 31, 2022 | 64.84% |
| September 30, 2022 | 64.84% |
| August 31, 2022 | 64.84% |
| July 31, 2022 | 64.84% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Biogen, Inc. | 72.66% |
| Gilead Sciences, Inc. | 26.58% |
| Agios Pharmaceuticals, Inc. | 82.86% |
| Arcutis Biotherapeutics, Inc. | 95.02% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 23.00 |
| Beta (5Y) | 0.8190 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.40% |
| Historical Sharpe Ratio (5Y) | 0.3693 |
| Historical Sortino (5Y) | 1.290 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.22% |